Nina Agrawal

5 days ago | bostonglobe.com | Nina Agrawal

By fall of 2024, Le had run out of conventional treatment options. That’s when Dr. Meghan Sise, her physician, offered her a chance to participate in a clinical trial that was testing a new therapy, borrowed from the field of cancer research. “Let’s try it,” Le told Sise, who is a principal investigator on the trial.

1 week ago | nytimes.com | Nina Agrawal |Pete Gamlen

La inflamación se ha convertido en una mala palabra. La culpamos de muchas enfermedades. Intentamos comer alimentos que la combaten. Tomamos medicamentos para mitigar el dolor que causa. Pero la inflamación, cuando funciona con normalidad, es una respuesta natural y útil del organismo para protegernos. Es la alarma que suena cuando nos infectamos con un virus y lo que ayuda a los huesos a curarse en los días y semanas posteriores a romperse un tobillo.

1 week ago | infobae.com | Nina Agrawal

Lupus ErythematosusAutoimmune DiseasesImmunotherapyImmune SystemKidneysCancerClinical TrialsMassachusetts General HospitalLa enfermedad puede ser debilitante y a veces mortal para los 3 millones de personas que la padecen. Un tratamiento llamado CAR-T parece detenerla en seco. La médica de Jennifer repasó una larga lista de síntomas de pies a cabeza mientras la examinaba en una clínica de Boston el mes pasado. ¿Tenía niebla mental? ¿Dolores de cabeza?

1 week ago | nytimes.com | Nina Agrawal

Jennifer Le’s doctor ticked through a long checklist of head-to-toe symptoms as she examined Ms. Le in a Boston clinic last month. Was she experiencing brain fog? Headaches? What about hair loss, rashes or joint pain? Ms. Le, 36, was diagnosed with lupus in 2016, just after she got married. She tried all the standard treatments, hoping that her symptoms would stabilize and she could one day get pregnant.

1 week ago | seattletimes.com | Nina Agrawal

A new study shows that appendix cancer is becoming more common among younger generations, mirroring a pattern that has been occurring with other cancers since the 1990s. Cancer incidence rates among members of Generation X were two to three times higher than among people born in the 1940s, according to the study, which was published last week in the Annals of Internal Medicine. Rates among older millennials, born in the 1980s, were more than four times higher.